Skip to content
paul_cornes_bw

Affiliation

Comparative Outcomes Group, Bristol UK

Country

United Kingdom

1. Current Status, Position

Dr Paul Cornes (BM BCH MA MRCP FRCR) is an Oncologist from Bristol, UK.

2. Education

Dr Paul Cornes trained in Medicine at Oxford University and in Oncology at the Royal Marsden Hospital, London, UK before becoming a Consultant Oncologist in Bristol, UK.

3. Research Area

Dr Paul Cornes is part of the steering group for the European School of Oncology Working Party on the Access to Innovation in Cancer Treatment. He was part of the team that developed and presented evidence to the Oncology Advisory drugs Committee of the FDA for the first successfully approved US biosimilar. He has been in the British Medical Journal’s “Round Table” group on Biosimilars and has been on the panel for the EU Commission biosimilars meeting in Brussels.

4. Conflict of interest: Dr Paul Cornes received honoraria from the following companies for speaking at meetings in 2016:

  • Amgen
  • Generic and Biosimilar Medecines Association – Australia
  • Merck Serono
  • Napp
  • Sandoz
×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.